Anish Suri, Ph.D., president & chief scientific officer (CSO) of Cue Biopharma, to transition to principal research and immunology advisor BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.
Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Thank you for standing by. My name is Kayla, and I will be your conference operator today. At this time, I’d like to welcome everyone to ...
Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Good morning, and welcome to Hyzon’s Third Quarter 2024 Earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback